Iron Triangle Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-265,076
| Closed | -$16.4M | – | 36 |
|
2022
Q3 | $16.4M | Buy |
265,076
+115,076
| +77% | +$7.12M | 2.87% | 20 |
|
2022
Q2 | $12M | Sell |
150,000
-353,744
| -70% | -$28.2M | 1.55% | 19 |
|
2022
Q1 | $53M | Buy |
503,744
+266,274
| +112% | +$28M | 6.3% | 2 |
|
2021
Q4 | $25.6M | Sell |
237,470
-336,997
| -59% | -$36.3M | 3.57% | 17 |
|
2021
Q3 | $62.9M | Sell |
574,467
-44,106
| -7% | -$4.83M | 9.03% | 1 |
|
2021
Q2 | $57.9M | Buy |
618,573
+118,573
| +24% | +$11.1M | 5.97% | 6 |
|
2021
Q1 | $46M | Sell |
500,000
-150,000
| -23% | -$13.8M | 5.85% | 5 |
|
2020
Q4 | $47.5M | Buy |
650,000
+300,000
| +86% | +$21.9M | 6.16% | 3 |
|
2020
Q3 | $27.2M | Sell |
350,000
-86,127
| -20% | -$6.69M | 6.08% | 4 |
|
2020
Q2 | $24.2M | Sell |
436,127
-63,873
| -13% | -$3.55M | 6.1% | 4 |
|
2020
Q1 | $14.8M | Buy |
500,000
+11,702
| +2% | +$347K | 5.73% | 3 |
|
2019
Q4 | $17.7M | Buy |
+488,298
| New | +$17.7M | 4.68% | 8 |
|